Biocompatible Reactive Oxygen Species (ROS)-Responsive Nanoparticles as Superior Drug Delivery Vehicles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biocompatible Reactive Oxygen Species (ROS)-Responsive Nanoparticles as Superior Drug Delivery Vehicles

Published:2014-08-22 Issue:1 Volume:4 Page:69-76
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Zhang Dinglin¹,Wei Yanling²,Chen Kai¹,Zhang Xiangjun¹,Xu Xiaoqiu¹,Shi Qing¹,Han Songling¹,Chen Xin³,Gong Hao²,Li Xiaohui³,Zhang Jianxiang¹

Affiliation:

1. Department of Pharmaceutics, College of Pharmacy; Third Military Medical University; Chongqing 400038 China

2. Department of Gastroenterology, Daping Hospital; Third Military Medical University; Chongqing 400042 China

3. Institute of Materia Medica; Third Military Medical University; Chongqing 400038 China

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Reference41 articles.

1. Reactive oxygen species in vascular biology: implications in hypertension

2. The oxygen sensing signal cascade under the influence of reactive oxygen species

3. Reconciling the chemistry and biology of reactive oxygen species

4. Cellular defenses against damage from reactive oxygen species

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive oxygen species (ROS)-responsive biomaterials for treating myocardial ischemia-reperfusion injury;Frontiers in Bioengineering and Biotechnology;2024-09-02

2. Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-28

3. Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology;Pharmacological Research;2024-08

4. An Osteoimmunomodulatory Biopatch Potentiates Stem Cell Therapies for Bone Regeneration by Simultaneously Regulating IL‐17/Ferroptosis Signaling Pathways;Advanced Science;2024-07-18

5. Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment;Drug Design, Development and Therapy;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3